Sharon Marie Dankwardt
Hoffmann-La Roche
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sharon Marie Dankwardt.
Tetrahedron Letters | 1995
Sharon Marie Dankwardt; Sherry R. Newman; John L. Krstenansky
Abstract An SNAr reaction on solid phase was demonstrated in the synthesis of a piperazine library using a combinatorial approach.
Molecular Diversity | 1996
Sharon Marie Dankwardt; Thu M. Phan; John L. Krstenansky
SummaryA non-peptide library of 2001 compounds has been prepared utilizing solid-phase techniques. The split/combine method was demonstrated to work well to form mixtures of compounds based on 3-amino-5-hydroxybenzoic acid as a core structure. The benzoic acid of the core structure served as the attachment point for the resin and the amino and hydroxy positions were variably substituted.
Bioorganic & Medicinal Chemistry Letters | 2000
Sharon Marie Dankwardt; Roland Joseph Billedeau; Linda K Lawley; Sarah C. Abbot; Robert L Martin; Christine S. Chan; Harold E. Van Wart; Keith Adrian Murray Walker
A solid-phase approach to the rapid synthesis of di- and tripeptide-like hydroxamic acids is presented. These compounds are shown to be potent inhibitors of procollagen C-proteinase (PCP).
Bioorganic & Medicinal Chemistry Letters | 2001
Sharon Marie Dankwardt; Robert L Martin; Christine S. Chan; Harold E. Van Wart; Keith Adrian Murray Walker; Nancy G. J. Delaet; Leslie Robinson
A discussion of the solid-phase synthesis of ornithine derived sulfonamide hydroxamic acids is illustrated. These analogues are shown to be potent, non-peptide inhibitors of procollagen C-proteinase (PCP).
Bioorganic & Medicinal Chemistry Letters | 2003
Leslie Robinson; D.M. Wilson; Nancy G. J. Delaet; E.K. Bradley; Sharon Marie Dankwardt; Jeffrey Allen Campbell; Robert L Martin; H.E. Van Wart; Keith Adrian Murray Walker; R.W. Sullivan
Glutamic acid derived hydroxamates were identified as potent and selective inhibitors of procollagen C-proteinase, an essential enzyme for the processing of procollagens to fibrillar collagens. Such compounds have potential therapeutic application in the treatment of fibrosis.
Bioorganic & Medicinal Chemistry Letters | 2002
Sharon Marie Dankwardt; Sarah C. Abbot; Chris Allen Broka; Robert L Martin; Christine S. Chan; Eric B. Springman; Harold E. Van Wart; Keith Adrian Murray Walker
Optimization of the amino acid side chain and the N-alkyl group of the sulfonamide of amino acid derived sulfonamide hydroxamates is discussed. The solid-phase synthesis of these potent inhibitors of procollagen C-proteinase (PCP) is presented. In addition, novel carboxylic acid sulfonamides were discovered to be PCP inhibitors.
Bioorganic & Medicinal Chemistry Letters | 1997
Sharon Marie Dankwardt; Steven W. Ferla; John L. Krstenansky; Sunil Bhakta; Helene Ostrelich; Kurt Jarnagin
A proposed overlap between cyclic hexapeptide Bradykinin antagonists and nonpeptide Bradykinin antagonists is discussed. Structural variations on both the peptides and nonpeptides support the proposed overlap based on an increase or decrease in the biological activities of the antagonists.
Bioorganic & Medicinal Chemistry Letters | 2003
Nancy G. J. Delaet; Leslie Robinson; D.M. Wilson; R.W. Sullivan; E.K. Bradley; Sharon Marie Dankwardt; Robert L Martin; H.E. Van Wart; Keith Adrian Murray Walker
The parallel synthesis of novel inhibitors of procollagen C-terminal proteinase is described. The synthetic strategy allowed for the facile synthesis of a large number of side-chain diversified diamino acid hydroxamates, of which the D-diaminopropionic acid derivatives were shown to be single digit nanomolar PCP inhibitors.
Archive | 1999
Sharon Marie Dankwardt; Wart Harold Edgar Van; Keith Adrian Murray Walker
Archive | 2002
Sharon Marie Dankwardt; Harold E. Van Wart; Keith Adrian Murray Walker